Mdma molecule:

Image from PubChem

Mdma Clinical Trials

An Open-Label Proof-of-Principle Study Testing the Use of an Additional MDMA-Assisted Therapy Session in People Who Relapsed After Participating in a Phase 2 Clinical Trial of MDMA-Assisted Therapy to Treat Chronic, Treatment-Resistant Posttraumatic Stress Disorder (PTSD)

To see complete record on, please visit this link

Id: NCT01458327

Organisation Name: Multidisciplinary Association for Psychedelic Studies

Overal Status: Completed

Start Date: November 2011

Last Update: July 6, 2022

Lead Sponsor: Multidisciplinary Association for Psychedelic Studies

Brief Summary: This study will consist of a single session of MDMA-assisted therapy with a full dose of MDMA for people who took part in a study of MDMA-assisted therapy in people with posttraumatic stress disorder (PTSD) whose PTSD symptoms returned to higher levels at least a year after the first MDMA sessions. The single session will be performed by the same pair of therapists who performed the sessions in the first study. People will have a preparatory session, the MDMA-assisted session and three non-drug sessions afterward. Their PTSD symptoms and symptoms of depression will be measured at the start of this study and two and 12 months after the session.

  • Posttraumatic Stress Disorder

Total execution time in seconds: 0.21097087860107